Mariam Gachechiladze
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy.
Zděblová Čermáková Z, Hurník P, Konvalinka D, Štembírek J, Paračková T, Resová K, Cvek J, Blažek T, Knybel L, Formánek M, Gachechiladze M, Jörger M, Soltermann A, Škarda J, Motyka O, Janoutová J. HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina (Kaunas) 2023; 59
14.02.2023HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy.
14.02.2023Medicina (Kaunas) 2023; 59
Zděblová Čermáková Zuzana, Hurník Pavel, Konvalinka David, Štembírek Jan, Paračková Tereza, Resová Kamila, Cvek Jakub, Blažek Tomáš, Knybel Lukáš, Formánek Martin, Gachechiladze Mariam, Jörger Markus, Soltermann Alex, Škarda Jozef, Motyka Oldřich, Janoutová Jana
LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma.
Gachechiladze M, Überall I, Skanderová D, Matchavariani J, Ibrahim M, Shani I, Smičková P, Kolek V, Cierna L, Kleine-Tebbe J, Stahel R, Joerger M, Soltermann A, Škarda J. LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma. Lung Cancer 2021; 156:129-135.
15.04.2021LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma.
15.04.2021Lung Cancer 2021; 156:129-135
Gachechiladze Mariam, Überall Ivo, Skanderová Daniela, Matchavariani J, Ibrahim M, Shani Ilay, Smičková Petra, Kolek Vítězslav, Cierna L, Kleine-Tebbe Jörg, Stahel R, Joerger M, Soltermann A, Škarda Josef
Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
Gachechiladze M, Škarda J, Bouchalova K, Soltermann A, Jörger M. Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors. Front Oncol 2020; 10:581217.
03.11.2020Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
03.11.2020Front Oncol 2020; 10:581217
Gachechiladze Mariam, Škarda Josef, Bouchalova Katerina, Soltermann Alex, Jörger Markus
Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma
Gachechiladze M, Soltermann A, Rulle U, Weder W, Stahel R, Kolář Z, Shani I, Hajduch M, Vbrková J, Vojta P, Smičková P, Kolek V, Überall I, Skanderová D, Škarda J, Jörger M. Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma. Lung Cancer 2020; 147:30-38.
23.06.2020Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma
23.06.2020Lung Cancer 2020; 147:30-38
Gachechiladze Mariam, Soltermann Alex, Rulle Undine, Weder Walter, Stahel Rolf, Kolář Zdeněk, Shani Ilay, Hajduch Marian, Vbrková Jana, Vojta Petr, Smičková Petra, Kolek Vítězslav, Überall Ivo, Skanderová Daniela, Škarda Josef, Jörger Markus
Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer
Überall I, Gachechiladze M, Jörger M, Anděl J, Smičková P, Kolek V, Grygárková I, Škarda J. Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer. Lung Cancer 2019; 129:85-91.
08.01.2019Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer
08.01.2019Lung Cancer 2019; 129:85-91
Überall Ivo, Gachechiladze Mariam, Jörger Markus, Anděl Josef, Smičková Petra, Kolek Vítězslav, Grygárková Ivona, Škarda Josef
RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
Gachechiladze M, Škarda J, Soltermann A, Jörger M. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies. Int J Cancer 2017; 141:1286-1294.
19.05.2017RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
19.05.2017Int J Cancer 2017; 141:1286-1294
Gachechiladze Mariam, Škarda Josef, Soltermann Alex, Jörger Markus
Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
Gachechiladze M, Soltermann A, Weder W, Stahel R, Baty F, Kolář Z, Bouchal J, Langová K, Grygárková I, Kolek V, Škarda J, Jörger M. Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer 2017; 105:31-38.
18.01.2017Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients
18.01.2017Lung Cancer 2017; 105:31-38
Gachechiladze Mariam, Soltermann Alex, Weder Walter, Stahel Rolf, Baty Florent, Kolář Zdeněk, Bouchal Jan, Langová Kateřina, Grygárková Ivona, Kolek Vítězslav, Škarda Josef, Jörger Markus